Skip to content
10-Q

Quarterly Report

Pulmonx Corp LUNG

0001127537-25-000026

← back to feed
Filed
May 2, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 25, 2025 40.26M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $29.39M
Long Term Debt Q1 2025 · Dec 31, 2024 $34M
Short Term Debt Q1 2025 · Mar 31, 2025 $7.8M
Short Term Debt Q1 2025 · Dec 31, 2024 $3.18M
Current Liabilities Q1 2025 · Mar 31, 2025 $24.95M
Current Liabilities Q1 2025 · Dec 31, 2024 $24.44M
Total Liabilities Q1 2025 · Mar 31, 2025 $73.07M
Total Liabilities Q1 2025 · Dec 31, 2024 $77.04M
Current Assets Q1 2025 · Mar 31, 2025 $123.94M
Current Assets Q1 2025 · Dec 31, 2024 $136.25M
Total Assets Q1 2025 · Mar 31, 2025 $150.74M
Total Assets Q1 2025 · Dec 31, 2024 $162.85M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $70.91M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $70.16M
Shares Diluted Q1 2025 · Mar 31, 2024 38.64M sh
Capex Q1 2025 · Mar 31, 2024 $451K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$11.8M
Stockholders Equity Q1 2025 · Mar 31, 2024 $110.5M
Stockholders Equity Q1 2025 · Dec 31, 2023 $118.32M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.36
Eps Basic Q1 2025 · Mar 31, 2024 −$0.36
Sga Expense Q1 2025 · Mar 31, 2024 $24.4M
Rd Expense Q1 2025 · Mar 31, 2024 $4.21M
Net Income Q1 2025 · Mar 31, 2024 −$13.75M
Operating Income Q1 2025 · Mar 31, 2024 −$14.54M
Gross Profit Q1 2025 · Mar 31, 2024 $14.08M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $4.78M
Revenue Q1 2025 · Mar 31, 2024 $18.85M